Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

1 pt

Opinion on AstraZeneca PLC (AZN) Sector: Healthcare > Industry: Major Drugs
Global pharma on the cheap with 3.3% div to boot

Jun 11, 2007 05:51 PM GMT

Yomain

Return	Risk
-58.03%	HIGH

Analyst

Profile & Performance

Subscribe to author

First-rate pharmaceutical co. offers reasonable dividend while waiting for proper valuation.

AZN: This call was made on 06/11/07 @ $52.13

Rating:	$52.13 (06/11/07)
Gain/Loss:	-13.20% in 897 days
Target:	$60.00 (+15.10%) in Six months
Allocation:	14.3% of portfolio

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.37%	379
2	Gerald Greene	18.14	+70.70%	209
3	stockmarketfunding.com	17.66	+25.67%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+78.05%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
MA	MasterCard Inc
DELL	Dell Inc
KO	The CocaCola Company
RIO	Companhia Vale Do Rio Doce
FRE	Freddie Mac
AMZN	Amazoncom Inc

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

PARD		PARD - Azimuth Opportunity Bets on Poniard's Survival. Should you ? by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla
NVO		Diabetes Care: Global Investing Opportunities by Mike Havrilla

... more »

AstraZeneca PLC (AZN)

SocialPicks Sentiment:

This Quarter's Sentiment:

All:

89.0%

Top:

100.0%

Get Daily Email Alerts

Subscribe to Yomain

Receive Free Ideas Daily for This Sector

Latest Picks by Yomain

Symbol	SP Sentiment	Return	Since
TXA	N/A	-75.74%	06/11/07
WIBC	N/A	-44.91%	06/11/07
CROX		-88.40%	06/11/07
TRB	N/A	n/a	06/11/07
BVF		-43.58%	06/11/07

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on AstraZeneca PLC (AZN) Sector: Healthcare > Industry: Major Drugs Global pharma on the cheap with 3.3% div to boot

Opinion on AstraZeneca PLC (AZN) Sector: Healthcare > Industry: Major Drugs
Global pharma on the cheap with 3.3% div to boot